跳至主要内容
临床试验/CTRI/2020/07/026522
CTRI/2020/07/026522已完成1 期

An Open Label, Single Arm, Clinical Study to Evaluate Efficacy and Safety of MNDV toothpaste in Dental Care of Healthy Adults.

MN Pharmaceuticals0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age: 18 to 55 years (both inclusive) at the time of consent.
  • Sex: Healthy male or non-pregnant/non-lactating females.
  • Females of Childbearing potential must have a negative urine pregnancy test performed on screening and enrollment visit.
  • Subjects are in good general health as determined by the Investigator on the basis of medical history.
  • Subjects having T-VSC reading (total volatile sulphur compounds) of >160 ppb (parts per billion)
  • Subjects with mild, moderate and severe plaque with plaque index 2-4.
  • Subjects with mild to moderate gingivitis with modified gingival index 0.1-0.3.
  • Subjects should be willing to come to the test site without brushing their teeth in the morning.
  • Subjects should be willing to not to consume anything except water after meal of previous night.
  • Subjects must be able to understand and provide written informed consent to participate in the study.
  • Subjects should be willing and able to follow the study directions to participate in the study.

排除标准

  • Subjects with orthodontic bands.
  • Subjects with plaque index of 0, 1 and 5
  • Subjects with partial removable dentures.
  • Subjects having tumor(s) of the soft or hard tissues of the oral cavity.
  • Subjects with advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone)
  • Subjects having carious lesion which requires immediate restorative treatment.
  • Subjects having used antibiotics anytime during the last three months prior to entry into the study.
  • Subjects having participated in any other dental clinical study within last six months prior to entry into the study.
  • Subjects with dental prophylaxis during the past two weeks prior to baseline examinations.
  • Subjects with history of allergies to any oral care/personal care consumer products or their ingredients.
  • Subjects on any prescription medicines that might interfere with the study outcome.
  • Subjects taking oral contraceptives and other medication based contraceptives.
  • Pregnant female subjects or female planning to get pregnant during study duration.
  • Consumption of any medicated sweets, chewing gum, breath fresheners etc. containing antimicrobial agents.
  • Subjects with diseases or having history that potentially can contribute to oral malodor (e.g. diabetes mellitus, bronchitis, tonsillitis, sinusitis etc.)
  • Subjects that consume alcohol.
  • Subjects that smoke cigarette or consume any other form of tobacco.

研究者

相似试验